See All Slides - tctmd.com

Slides

Presentation TCT 2012

Late Complication After Rotational Atherectomy

Presenter: Edouard Benit

October 24, 2012

Presentation TCT 2012

Management of Fibromuscular Dysplasia of the Carotid Artery

Presenter: Jeffrey Olin

October 24, 2012

Presentation TCT 2012

Percutaneous Mitral Valve: Where It Fits in Japan-US Today

Presenter: David Reuter

October 24, 2012

Presentation TCT 2012

Troubleshooting Loss of Visualization During Dissection Reentry

Presenter: James Spratt

October 24, 2012

Presentation TCT 2012

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Presenter: Adnan Kastrati

October 24, 2012

Presentation TCT 2012

Minimally Invasive Mitral Repair: Is It for Everyone (Surgeon and Patient)?

Presenter: A. Marc Gillinov

October 24, 2012

Presentation TCT 2012

"Impact of the Presence and Extent of Incomplete Angiographic Revascularization after Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial."...

Presenter: Gregg Rosner

October 24, 2012

Presentation TCT 2012

Assessing the Market (Without Hiring an MBA)

Presenter: Jay Watkins

October 24, 2012

Presentation TCT 2012

Clopidogrel Is Still the Choice for Most!

Presenter: Shamir Mehta

October 24, 2012

Presentation TCT 2012

Elective PCI of Triple Vessel Disease with Coronary Perforation and Emergency CABG

Presenter: Olli Kajander

October 24, 2012

Advertisement

Slides

Late Complication After Rotational Atherectomy

Management of Fibromuscular Dysplasia of the Carotid Artery

Percutaneous Mitral Valve: Where It Fits in Japan-US Today

Troubleshooting Loss of Visualization During Dissection Reentry

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Minimally Invasive Mitral Repair: Is It for Everyone (Surgeon and Patient)?

"Impact of the Presence and Extent of Incomplete Angiographic Revascularization after Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial."...

Assessing the Market (Without Hiring an MBA)

Clopidogrel Is Still the Choice for Most!

Elective PCI of Triple Vessel Disease with Coronary Perforation and Emergency CABG

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content